title: Suppression of allorecognition by use of synthetic peptides.
authors.affiliation: Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA.
authors.forename: A I
authors.initials: AI
authors.lastname: Colovai
authors.forename: E
authors.initials: E
authors.lastname: Renna-Molajoni
authors.forename: P L
authors.initials: PL
authors.lastname: Cocciolo
authors.forename: S
authors.initials: S
authors.lastname: Tugulea
authors.forename: Z
authors.initials: Z
authors.lastname: Liu
authors.forename: P E
authors.initials: PE
authors.lastname: Harris
authors.forename: N
authors.initials: N
authors.lastname: Suciu-Foca
authors.forename: R
authors.initials: R
authors.lastname: Cortesini
mesh_terms: D000595:Amino Acid Sequence; D000938:Antigen-Presenting Cells / Q000187:drug effects / Q000276:immunology* / Q000528:radiation effects; D002478:Cells, Cultured; D002999:Clone Cells; D006684:HLA-DR Antigens / Q000737:chemistry / Q000276:immunology*; D059810:HLA-DR Serological Subtypes; D006801:Humans; D008213:Lymphocyte Activation; D010446:Peptide Fragments / Q000737:chemistry / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000737:chemistry / Q000276:immunology; D013329:Structure-Activity Relationship; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
chemical_list: D006684:HLA-DR Antigens; D059810:HLA-DR Serological Subtypes; C080766:HLA-DR11 antigen; D010446:Peptide Fragments; D011994:Recombinant Proteins